EU CAR-T Race Tightens After Yescarta Reverts To Standard Review

 
• By Maureen Kenny

Kite and Novartis are vying to be the first company to have a CAR-T therapy approved in the EU. Both companies are hoping to be able to treat patients with r/r DLBCL.

Kart crossing the finish line
The CAR-T race in the EU could have a close finish • Source: Shutterstock

More from Europe

More from Geography